Christopher Griffith
Clinical Genetics (M.D.) Fort Myers, FL Medical Doctor
NPI 1437152832 CMS profile 489463
16230 Summerlin Rd Ste 215, Fort Myers, FL 33908
General payments
$49
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$28,223
Through program year 2023, Christopher Griffith of Fort Myers, FL is reported in the CMS Open Payments database as having received $49 across 2 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $28,223 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 16th percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $49 | 2 |
Beside peers
- Christopher Griffith
- Clinical Genetics (M.D.) median
- Middle half of Clinical Genetics (M.D.)
- National median
In program year 2025, general payments to Christopher Griffith were reported at $0. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.
Show as a table
| Year | Christopher Griffith | Clinical Genetics (M.D.) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $130 | $24–$2,691 | $163 |
| 2020 | $0 | $126 | $30–$3,700 | $114 |
| 2021 | $0 | $185 | $30–$3,777 | $132 |
| 2022 | $0 | $136 | $44–$2,749 | $149 |
| 2023 | $49 | $196 | $55–$5,220 | $160 |
| 2024 | $0 | $165 | $46–$3,171 | $164 |
| 2025 | $0 | $255 | $85–$3,583 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
85
Drug cost
$3,365,720
Branded share of claims
83.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Xenpozyme Olipudase Alfa-Rpcp | Brand | 13 | $1,864,628 | |
| Galafold Migalastat Hcl | Brand | 34 | $1,083,928 | |
| Fabrazyme Agalsidase Beta | Brand | 24 | $417,107 | |
| Diphenhydramine Hcl | Generic | 14 | $56 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Billing to Medicare
Part B · data year 2024 · 8 billing codesPaid by Medicare
$2,297
Medicare patients
20
Services billed
24
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Genetics (M.D.) in Florida
Roberto Zori
Clinical Genetics (M.D.) · Gainesville, FL
Amarilis Sanchez Valle
Clinical Genetics (M.D.) · Tampa, FL
Paldeep Atwal
Clinical Genetics (M.D.) · West Palm Beach, FL
Parul Jayakar
Clinical Genetics (M.D.) · Miami, FL
Deborah Barbouth
Clinical Genetics (M.D.) · Miami, FL
Ingrid Cristian
Clinical Genetics (M.D.) · Orlando, FL
Related records
Clinical Genetics (M.D.) in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Genetics (M.D.)
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.